PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.
公司网站 :
http://www.polypid.com
总经理:Dikla Czaczkes Akselbrad
建立时间:2008
公司总部:Petach Tikva
领域:Health technology
行业:Pharmaceuticals: major